BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2052693)

  • 1. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc.
    Dubois JM; Sebag GH; De Prost Y; Teillac D; Chretien B; Brunelle FO
    Radiology; 1991 Jul; 180(1):195-8. PubMed ID: 2052693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of low-pressure vascular malformations by injection of Ethibloc. Study of 19 cases and analysis of complications].
    Baud AV; Breton P; Guibaud L; Freidel M
    Rev Stomatol Chir Maxillofac; 2000 Oct; 101(4):181-8. PubMed ID: 11103425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Venous vascular malformations and their treatment with Ethibloc].
    Herbreteau D; Riche MC; Enjolras O; Lemarchand F; Laurian C; Brette MD; Merland JJ
    J Mal Vasc; 1992; 17(1):50-3. PubMed ID: 1588234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of venous malformations in children and implications for sclerotherapy.
    Puig S; Aref H; Chigot V; Bonin B; Brunelle F
    Pediatr Radiol; 2003 Feb; 33(2):99-103. PubMed ID: 12557065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein.
    Dubois J; Garel L; Abela A; Laberge L; Yazbeck S
    Radiology; 1997 Sep; 204(3):651-4. PubMed ID: 9280239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistent varicocele following high ligation of the internal spermatic vein. Phlebography and vaso-occlusion with ethibloc].
    Buck J; Rassweiler J; Leibbrand M; Miller K; Eisenberger F
    Rofo; 1986 Mar; 144(3):263-7. PubMed ID: 3008226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
    Borsik M; Herbreteau D; Deffrennes D; Guichard JP; Aymard A; Merland JJ; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 1992; 109(5):273-6. PubMed ID: 1292384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of capillary-venous malformations using a new fibrosing agent.
    Riche MC; Hadjean E; Tran-Ba-Huy P; Merland JJ
    Plast Reconstr Surg; 1983 May; 71(5):607-14. PubMed ID: 6836059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children.
    Emran MA; Dubois J; Laberge L; Al-Jazaeri A; Bütter A; Yazbeck S
    J Pediatr Surg; 2006 May; 41(5):975-9. PubMed ID: 16677896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of large head and neck capillaro-venous malformation by a fibrosing agent.
    Fradis M; Podoshin L; Simon J; Lazarov N; Shagrawi I; Boss JH
    J Laryngol Otol; 1989 Apr; 103(4):390-8. PubMed ID: 2715693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients.
    Gelbert F; Enjolras O; Deffrenne D; Aymard A; Mounayer C; Merland JJ
    Neuroradiology; 2000 Sep; 42(9):692-6. PubMed ID: 11071446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystic lymphatic malformations of the head and neck. Role of interventional radiology].
    Herbreteau D; Guichard JP; Gobin YP; Aymard A; Casasco A; Borsik M; Houdard E; Enjolras O; Riche MC; Reizine D
    Ann Otolaryngol Chir Cervicofac; 1992; 109(5):258-63. PubMed ID: 1292382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy.
    Boardman SJ; Cochrane LA; Roebuck D; Elliott MJ; Hartley BE
    Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):270-6. PubMed ID: 20231646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aneurysmal bone cysts in children: complications of fibrosing agent injection.
    Topouchian V; Mazda K; Hamze B; Laredo JD; Penneçot GF
    Radiology; 2004 Aug; 232(2):522-6. PubMed ID: 15215542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ethibloc--a nonsurgical alternative in the treatment of cervicofacial lymphangiomas in children].
    Reychler H
    Acta Stomatol Belg; 1987 Oct; 84(3):257-64. PubMed ID: 3327375
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients.
    Herbreteau D; Riche MC; Enjolras O; Khayata M; Lemarchand-Venencie F; Borsik M; Brette MD; Reizine D; Merland JJ
    Int Angiol; 1993 Mar; 12(1):34-9. PubMed ID: 8376909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cystic lymphatic malformations and their treatment].
    Herbreteau D; Riche MC; Enjolras O; Lemarchand F; Brette MD; Laurian C; Merland JJ
    J Mal Vasc; 1992; 17(1):54-6. PubMed ID: 1588235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Ethibloc in the treatment of cystic and venous angiomas in children. 19 cases.
    Brevière GM; Bonnevalle M; Pruvo JP; Besson R; Marache P; Herbaux P; Debeugny P
    Eur J Pediatr Surg; 1993 Jun; 3(3):166-70. PubMed ID: 8353118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic investigation of vascular malformations of the face after transarterial embolization with ethibloc and other agents.
    Niechajev I; Clodius L
    Plast Reconstr Surg; 1990 Oct; 86(4):664-71; discussion 672-4. PubMed ID: 2217580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.